Skip to main content

2025 measles resurgence carries estimated $244M price tag

By CIDRAP.umn.edu  
   February 27, 2026

A new non–peer-reviewed study estimates that measles outbreaks in the United States cost more than $244 million in 2025 alone and warns that even modest declines in childhood MMR vaccination could trigger billions of dollars in additional losses over the next five years. MMR vaccine coverage among U.S. kindergarteners has fallen steadily since the 2019–20 school year, alongside a national resurgence of measles. In 2025, the United States recorded its highest annual measles count since 1992, at 2,280 cases.

Full story


Get the latest on healthcare leadership in your inbox.